Page last updated: 2024-09-04

atazanavir sulfate and 3,9-bis((ethylthio)methyl)-k-252a

atazanavir sulfate has been researched along with 3,9-bis((ethylthio)methyl)-k-252a in 1 studies

Compound Research Comparison

Studies
(atazanavir sulfate)
Trials
(atazanavir sulfate)
Recent Studies (post-2010)
(atazanavir sulfate)
Studies
(3,9-bis((ethylthio)methyl)-k-252a)
Trials
(3,9-bis((ethylthio)methyl)-k-252a)
Recent Studies (post-2010) (3,9-bis((ethylthio)methyl)-k-252a)
1,1022465907349

Protein Interaction Comparison

ProteinTaxonomyatazanavir sulfate (IC50)3,9-bis((ethylthio)methyl)-k-252a (IC50)
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.209
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.039
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.043
Mitogen-activated protein kinase kinase kinase 9Homo sapiens (human)0.0413
Protein delta homolog 1Homo sapiens (human)0.114
Mitogen-activated protein kinase kinase kinase 10Homo sapiens (human)0.0412
Mitogen-activated protein kinase kinase kinase 11Homo sapiens (human)0.0364

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dewhurst, S; DiFrancesco, R; Gelbard, HA; Gendelman, HE; Hochreiter, JS; Ma, Q; Maggirwar, SB; Morse, GD; Peterson, DR; Schifitto, G1

Other Studies

1 other study(ies) available for atazanavir sulfate and 3,9-bis((ethylthio)methyl)-k-252a

ArticleYear
Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients.
    Journal of neurovirology, 2013, Volume: 19, Issue:3

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbazoles; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Half-Life; HIV Infections; HIV-1; Humans; Male; MAP Kinase Kinase Kinases; Middle Aged; Nootropic Agents; Oligopeptides; Protein Kinase Inhibitors; Pyridines; Ritonavir

2013